These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18059332)

  • 21. Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo.
    Zolfaghari R; Cifelli CJ; Lieu SO; Chen Q; Li NQ; Ross AC
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1029-36. PubMed ID: 17185629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
    Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of the 5-lipoxygenase pathway and its cellular localization in Barrett's adenocarcinoma.
    Boger PC; Shutt JD; Neale JR; Wilson SJ; Bateman AC; Holloway JW; Patel P; Sampson AP
    Histopathology; 2012 Sep; 61(3):509-17. PubMed ID: 22690932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.
    Lagorce-Pagès C; Paraf F; Wendum D; Martin A; Fléjou JF
    Virchows Arch; 2004 May; 444(5):426-35. PubMed ID: 15045585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma.
    Wu GD; Beer DG; Moore JH; Orringer MB; Appelman HD; Traber PG
    Gastroenterology; 1993 Sep; 105(3):837-44. PubMed ID: 8359653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase.
    Lutz JD; Dixit V; Yeung CK; Dickmann LJ; Zelter A; Thatcher JE; Nelson WL; Isoherranen N
    Biochem Pharmacol; 2009 Jan; 77(2):258-68. PubMed ID: 18992717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
    Hu L; Lv JF; Zhuo W; Zhang CM; Zhou HH; Fan L
    J Pharm Pharmacol; 2016 Sep; 68(9):1193-202. PubMed ID: 27366899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells.
    Si J; Fu X; Behar J; Wands J; Beer DG; Souza RF; Spechler SJ; Lambeth D; Cao W
    J Biol Chem; 2007 Jun; 282(22):16244-55. PubMed ID: 17403674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.
    Shirvani VN; Ouatu-Lascar R; Kaur BS; Omary MB; Triadafilopoulos G
    Gastroenterology; 2000 Mar; 118(3):487-96. PubMed ID: 10702199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase.
    Thatcher JE; Buttrick B; Shaffer SA; Shimshoni JA; Goodlett DR; Nelson WL; Isoherranen N
    Mol Pharmacol; 2011 Aug; 80(2):228-39. PubMed ID: 21521770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic regulatory mechanisms distinguish retinoic acid-mediated transcriptional responses in stem cells and fibroblasts.
    Kashyap V; Gudas LJ
    J Biol Chem; 2010 May; 285(19):14534-48. PubMed ID: 20231276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple retinoic acid response elements cooperate to enhance the inducibility of CYP26A1 gene expression in liver.
    Zhang Y; Zolfaghari R; Ross AC
    Gene; 2010 Sep; 464(1-2):32-43. PubMed ID: 20682464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system.
    Lee SJ; Perera L; Coulter SJ; Mohrenweiser HW; Jetten A; Goldstein JA
    Pharmacogenet Genomics; 2007 Mar; 17(3):169-80. PubMed ID: 17460545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid-metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy.
    Han BC; Xia HF; Sun J; Yang Y; Peng JP
    J Cell Physiol; 2010 May; 223(2):471-9. PubMed ID: 20112286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of expression of the retinoic acid metabolizing enzyme CYP26A1 in uteri of ovariectomized mice after treatment with ovarian steroid hormones.
    Fritzsche B; Vermot J; Neumann U; Schmidt A; Schweigert FJ; Dollé P; Rühl R
    Mol Reprod Dev; 2007 Feb; 74(2):258-64. PubMed ID: 16955405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.
    Lord RV; Tsai PI; Danenberg KD; Peters JH; Demeester TR; Tsao-Wei DD; Groshen S; Salonga D; Park JM; Crookes PF; Kiyabu M; Chandrasoma P; Danenberg PV
    Surgery; 2001 Mar; 129(3):267-76. PubMed ID: 11231454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
    Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
    Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.
    Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J
    J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
    Herszenyi L; Hritz I; Pregun I; Sipos F; Juhasz M; Molnar B; Tulassay Z
    World J Gastroenterol; 2007 Feb; 13(5):676-82. PubMed ID: 17278189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.